A shortcut to identifying small molecule signals that regulate behavior and development in Caenorhabditis elegans by Pungaliya, Chirag et al.
1 
 
 
Supporting Tables and Methods 
 
 
A shortcut to identifying small molecule signals that regulate behavior and 
development in Caenorhabditis elegans 
 
Chirag Pungaliya1, Jagan Srinivasan2, Bennett W. Fox1, Rabia U. Malik1, Andreas H. Ludewig1, 
Paul W. Sternberg2 and Frank C. Schroeder1* 
 
 
1. Boyce Thompson Institute and Department of Chemistry and Chemical Biology, Cornell 
University, Ithaca, NY 14853. 
2. Howard Hughes Medical Institute and Division of Biology, California Institute of Technology, 
1200 E. California Blvd, Pasadena, CA 91125. 
 
∗Corresponding Author: schroeder@cornell.edu 
 
 
 
2 
 
Supporting Table S1 1H (600 MHz), 13C (126 MHz), and HMBC NMR spectroscopic data for 
ascr#6.1 in methanol-d4. Chemical shifts were referenced to δ(CD2HOD) = 3.31 ppm and 
δ(CD2HOD) = 49.05 ppm. Coupling constants are given in Hertz [Hz]. 
 
Position δ 13C [ppm] δ 1H [ppm] 1H-1H coupling 
constants 
Relevant HMBC 
Correlations 
1 23.2 1.165 J1,2 = 6.2 C-2, C-3 
2 67.83 3.73   
3 35.9 1.48   
  1.59   
4 34.2 1.65   
  1.65   
5 72.2 3.79   
6 19.0 1.14 J5,6 = 6.1 C-4, C-5 
     
2’ 97.1 4.65  C-5, C-3', C-4’,  
C-6’ 
3’ 69.6 3.72 J2’,3’ = 1.6, J3’,4’ax = 3.1 C-5’ 
4’ 35.6 1.77 (ax) J4’ax,5’ = 11.4,  
J4’ax,4’eq = 13.1 
C-5’, C-6’ 
  1.95 (eq) J3’,4’eq = 3.6 C-2’, C-3', C-5',  
C-6’ 
5’ 67.9 3.52 J4’eq,5’ = 3.7 C-6’ 
6’ 70.9 3.63 J5’,6’ = 9.4 C-4’, C-6’ 
6’-CH3 17.7 1.21 J6’,6’-CH3 = 6.2 C-5’, C-6’ 
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Supporting Table S2 1H (600 MHz), 13C (126 MHz), and HMBC NMR spectroscopic data for 
ascr#6.2 in methanol-d4. Chemical shifts were referenced to δ(CD2HOD) = 3.31 ppm and 
δ(CD2HOD) = 49.05 ppm. Coupling constants are given in Hertz [Hz]. 
 
Position δ 13C [ppm] δ 1H [ppm] 1H-1H coupling 
constants 
Relevant HMBC 
Correlations 
1 23.2 1.163 J1,2 = 6.2 C-2, C-3 
2 68.53 3.73   
3 35.9 1.48   
  1.59   
4 34.2 1.65   
  1.65   
5 72.2 3.79   
6 19.0 1.14 J5,6 = 6.1 C-4, C-5 
     
2’ 97.12 4.65  C-5, C-3’, C-4’,  
C-6’ 
3’ 69.58 3.72 J2’,3’ = 1.6, J3’,4’ax = 3.1 C-5' 
4’ 35.60 1.77 (ax) J4’ax,5’ = 11.4,  
J4’ax,4’eq = 13.1 
C-5’, C-6’ 
  1.95 (eq) J3’,4’eq = 3.6 C-2’, C-3’, C-5’,  
C-6’ 
5’ 67.94 3.52 J4’eq,5’ = 3.7 C-6’ 
6’ 70.87 3.63 J5’,6’ = 9.4 C-4’, C-6’ 
6’-CH3 17.79 1.21 J6’,6’-CH3 = 6.2 C-5’, C-6’ 
 
 
 
 
 
 
 
4 
 
Supporting Table S3 1H (600 MHz), 13C (126 MHz), and HMBC NMR spectroscopic data for 
ascr#7 in methanol-d4. Chemical shifts were referenced to δ(CD2HOD) = 3.31 ppm and 
δ(CD2HOD) = 49.05 ppm. Coupling constants are given in Hertz [Hz]. 
 
Position δ 13C [ppm] δ 1H [ppm] 1H-1H coupling 
constants 
Relevant HMBC 
Correlations 
1 170.1    
2 122.8 5.84 J2,3 = 15.3, J2,4 = 1.5 C-1, C-4 
3 150.8 6.99 J3,4 = 6.8 C-1, C-4, C-5 
4 29.4 2.40  C-2, C-3, C-5 
  2.33   
5 36.8 1.70  C-3, C-4, 
  1.65   
6 71.6 3.83  C-4, C-5, C-2’ 
7 19.2 1.16 J6,7 = 6.1 C-5, C-6 
     
2’ 97.4 4.66  C-3’,C-4’, C-6’ 
3’ 69.9 3.73 J2’,3’ = 1.6  
J3’,4’ax = 3.1 
C-5’ 
4’ 36.0 1.78 (ax) J4’ax,5’ = 11.4,  
J4’ax,4’eq = 13.0 
 
  1.96 (eq) J3’,4’eq = 3.4 C-3’, C-5’ 
5’ 68.4 3.52 J4’eq,5’ = 4.5  
6’ 71.3 3.61 J5’,6’ = 9.4 C-4’ 
6’-CH3 18.2 1.22 J6’,6’-CH3 = 6.3 C-5’, C-6’ 
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Supporting Table S4 1H (600 MHz), 13C (126 MHz), and HMBC NMR spectroscopic data for 
ascr#8 in methanol-d4. Chemical shifts were referenced to δ(CD2HOD) = 3.31 ppm and 
δ(CD2HOD) = 49.05 ppm. Coupling constants are given in Hertz [Hz]. 
 
Position δ 13C [ppm] δ 1H [ppm] 1H-1H coupling 
constants 
Relevant HMBC 
Correlations 
1’ 166.4    
2’ 125.0 6.17 J2’,3’ = 15.3, J2’,4’ = 1.5 C-1’, C-4’ 
3’ 147.2 6.98 J3’,4’ = 6.8  C-1’, C-4’,C-5’ 
4’ 29.1 2.44  C-2’, C-3’, C-5’ 
  2.38   
5’ 36.8 1.78  C-3’, C-4’, C-2' 
  1.69   
6’ 71.4 3.86  C-4’, C-5’ 
7’ 19.0 1.18 J6’,7’ = 6.1 C-5’, C-6’ 
     
2’’ 97.4 4.68  C-3’’, C-4’’,C-6’’ 
3’’ 68.5 3.74 J2’’,3’’ = 1.6,  
J3’’,4’’ax = 3.1 
C-5’’ 
4’’ 35.8 1.80 (ax) J4’’ax,5’’ = 11.2, 
J4’’ax,4’’eq = 13.0 
 
  1.97 (eq) J3’’, 4’’eq = 3.6 C-2’’, C-3’’,C-5’’, 
C-6’’ 
5’’ 68.0 3.51 J4’’eq,5’’ = 3.6  
6’’ 71.1 3.63 J5’’,6’’ = 9.4 C-4’’ 
6’’-CH3 18.1 1.22 J6’’,6’’-CH3 = 6.0 C-5’’, C-6’’ 
     
1 132.3    
2 131.1 7.63  C-4, C-6, 1-COOH
3 119.8 7.96  C-1, C-5 
4 142.4    
5 119.8 7.96  C-1, C-5, 1-COOH
6 131.0 7.63  C-4, C-6 
1-COOH 174.4    
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Supporting Methods –  
1. Differential Analysis by 2D-NMR Spectroscopy. Crude metabolite extract (derived from 
500 ml of daf-22 or N2 liquid culture) was adsorbed on 4 g of Celite and dry loaded into a empty 
25 g solid-load sample cartridge and filtered over a RediSep® Normal-Phase Silica Flash 
Column using a dichloromethane-methanol solvent system, starting with 5 min of 100% 
dichloromethane, followed by a linear increase of methanol content up to 10% at 10 min, 
followed by an increase of methanol content to 100% at 25 min.  Fractions eluting with up to 
50% methanol were combined, evaporated to dryness, and 30-50 mg of the residue was 
suspended in 0.75 mL of methanol-d4. The suspension was centrifuged to remove insoluble 
materials, and the supernatant was subjected to NMR spectroscopic analysis. 
The 1H NMR spectra of metabolite extracts derived from different batches of liquid 
culture frequently revealed considerable variation of proton chemical shift values. For example, 
the chemical shift of the proton in position 2 of nicotinic acid, a component of the media present 
in all metabolite extracts, varied between 8.6 and 8.7 ppm. Such variation of chemical shift 
values between samples must be minimized for successful comparison of 2D NMR spectra via 
overlays. In order to reduce chemical shift variation between different samples, we carefully 
adjusted the pH values of all metabolite extracts prior to 2D NMR-spectroscopic analysis. For 
this purpose, we titrated the metabolite extracts with 5% acetic acid-d4 in methanol-d4, using the 
proton chemical shifts of nicotinic acid as an indicator for change in pH. Chemical shift 
variability was greatly reduced by using this method, significantly improving the quality of the 
dqfCOSY overlays. High-resolution dqfCOSY spectra were acquired using the following 
parameters: acquisition time 0.6 s; 75 increments (ni) per 1 ppm of sweep width. Phase cycling 
was used for coherence selection, and MestreC was used to process the resulting data, zero-
filling the spectra to 8096 complex data points in the directly detected dimension (F2) and 2048 
data points in the indirectly detected dimension (F1).  Bitmaps derived from absolute-value 
processed dqfCOSY spectra were then imported into Adobe Photoshop CS3 and overlayed as 
described in reference 1. Various combinations of difference and multiply filters were used to 
highlight components that were distinctly present or absent in the N2 and daf-22 spectra.  
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2. Mating assay. The mating assays were performed as previously described2. All assays were 
conducted at 20 oC and each ascaroside was tested on at least two different days. For dose 
response curves, each dilution was tested on at least three different days.  
3. Dauer formation assay. Standard methods were used to grow worms in liquid cultures, 
modified as follows3. Worms were washed into two 5 cm NGM plate into a 15 ml falcon tube, 
treated with 5 ml of bleach solution (7 ml dH2O, 2 ml bleach, 1 ml 5 M KOH), and vortexed for 
90 s. Subsequently, the worms were pelleted using a tabletop centrifuge, and the supernatant was 
removed. Additional 2 ml of bleach solution was added and the tube was vortexed for 5 minutes 
until all worms had dissolved. The tube was then centrifuged for 1 minute to pellet the eggs. The 
supernatant was removed and the eggs were washed twice with S-complete medium. 
For the dauer assay, eggs were suspended in 2 ml of S-complete medium at a 
concentration of 1 egg/µl, and E. coli (HB101) was added for a final concentration of 0.5 mg/ml. 
Aqueous solutions of ascarosides were added to achieve two different concentrations (40 nM and 
200 nM) and the worms were grown at 20 oC on the carousel. After 6 days, dauer formation was 
assessed by soaking the worms in 1% SDS and counting worms that are resistant to SDS4. Each 
compound was tested at least 5 times on 5 different days. 
4. Partial purification of ascr#8, ascr#6.1, and ascr#6.2. The following chromatographic 
fractionations were monitored for the presence of signals the double bond and aromatic spin 
systems of ascr#8 by using 1H and dqfCOSY NMR spectra.  
Metabolite extract derived from 20 L of wildtype (N2) liquid culture was fractionated 
over a 1 kg-reversed-phase (Sigma-Aldrich octadecyl-functionalized silica gel) column, using a 
gradient solvent system starting with 4% methanol in water containing 1% of acetic acid. The 
methanol content was increased step-wise up to 100%.  The fraction eluting at a methanol 
content of 10-20% was evaporated to dryness and fractionated further using normal-phase 
column chromatography on silica, using dichloromethane-methanol mixtures as solvent, starting 
with 10% methanol, which was increased step-wise to 50%. ascr#8 containing-fractions 
containing were re-fractionated via reversed-phase column chromatography using a 13 g C18 
RediSep column (Teledyne ISCO) using methanol-water mixtures as solvent, starting with 10% 
of methanol, which, after 3 min, was increased linearly to 100% over 24 min.  One main fraction 
containing ascarosides ascr#6.1, ascr#6.2, and ascr#8 was obtained, which was characterized by 
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dqfCOSY, TOCSY, NOESY, and HMBC spectra.  Additionally, this mixture was characterized 
via HPLC-MS using a Supelco Discovery HS C-18 column (25 cm x 10 mm, 5 µm particle 
diameter) and a water-methanol solvent gradient starting with 20% methanol, which was 
increased to 100% over a period 30 min. ESI-MS (m/z) for ascr#8: [M+Na]+ calcd. for 
C20H27NO7Na, 416.4; found, 416.4. ESI-MS (m/z) for ascr#6.1 and 6.2: [M+Na]+ calcd. for 
C12H24O5Na, 271.3; found, 271.3. 
5. Identification of long-chained ascarosides in daf-22 metabolite extracts. Metabolite extract 
derived from 4 L of daf-22 liquid culture was chromatographed over silica, using a 7:1 
dichloromethane:methanol mixture containing 2% acetic acid as solvent. Fractions were 
analyzed by 1H and dqfCOSY NMR spectroscopy, and ascaroside-containing fractions were 
pooled, evaporated in vacuo and rechromatographed using dichloromethane:methanol mixtures 
as solvent, linearly increasing methanol content from 4% to 10%.  NMR spectroscopic analysis 
of fractions eluting at a methanol concentration of 7% revealed the presence of ascarosides, 
which positive-ion electrospray analysis showed to correspond to a mixture of long-chained 
derivatives5. Major components were 28-(3’R,5’R-dihydroxy-6’S-methyl-(2H)-tetrahydropyran-
2-yloxy)-2-nonacosanol (positive-ion ESI-MS (m/z): [M+Na]+ calcd. for C35H70O5Na, 593.5; 
found, 593.5) and 30-(3’R,5’R-dihydroxy-6’S-methyl-(2H)-tetrahydropyran-2-yloxy)-2-
untriacontanol (positive ion ESI-MS (m/z): [M+Na]+ calcd. for C37H74O5Na, 621.5; found, 
621.5).  In addition, variable amounts of 5’-O-acetylated derivatives of these long-chained 
ascarosides occur in both wild-type and daf-22 extracts [characteristic NMR-spectroscopic data 
for the acetylated derivatives: 1H NMR (600 MHz, acetone-d6) 1.10 (d, J = 6.2 Hz, 6’-CH3), 1.11 
(d, J = 6.2 Hz, 3 H, 2’-O-CH-CH3{side chain}), 1.45 (m, 1 H, 2’-O-CH-CHH{side chain}),  1.55 
(m, 1 H, 2’-O-CH-CHH{side chain}),  1.79 (ddd, J = 13.8, J = 11.5, J = 3.1 Hz, 1 H, 4’-Hax), 
2.02 (m, 1 H, 4’-Heq), 3.73 (td, J = 3.1, J = 1.5 Hz, 1 H, 3’-H), 3.77 (m, 1 H, 2’-O-CH{side 
chain}), 3.81 (dq, J = 9.8, J = 6.3 Hz, 1 H, 6’-H), 4.69 (br. s, 1 H 2’-H), 4.86 (ddd, J = 11.3, J = 
9.8, J = 4.8 Hz, 1 H 5’-H); 13C NMR (126 MHz, acetone-d6) 18.6 (6’-CH3), 20.1 (2’-O-CH-
CH3{side chain}), 33.7 (C-3’), 38.6 (2’-O-CH-CH2{side chain}), 68.3 (C-6’), 69.6 (C-3’), 71.3 
(C-5’), 72.5 (2’-O-C{side chain}), 97.9 (C-2’); NMR-spectroscopic signals of the acetyl group; 
1H NMR (600 MHz, acetone-d6) 2.00 (s, 3 H); 13C NMR (126 MHz, acetone-d6) 21.8, 170.9].  
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6. Syntheses 
6.1 2R-hex-5-enol: 
 
A multi-neck round bottom flask under argon was fitted with a 100-mL dropping funnel was 
charged with magnesium (5.16 g, 215 mmol), THF (50 ml), and a single crystal of iodine.  The 
addition funnel was charged with allyl bromide (15.72 g, 130 mmol) and THF (50 mL).  A 5-mL 
portion of the allyl bromide solution was added and the Mg-containing suspension was allowed 
to stir until the brown color disappeared.  After waiting an additional ten minutes, the remaining 
allyl bromide/THF solution was added drop-wise over a 90-minute period.  Following 
completion of addition, the mixture was allowed to stir for an additional hour.  The mixture was 
brought to -40 °C and copper iodide (620 mg, 3.25 mmol) was added.  The resulting light green 
mixture was allowed to stir an additional 30 min, at which time R-propylene oxide (2.5 g, 43 
mmol) in THF (20 ml) was added in a single portion.  The mixture was allowed to warm to -15 
°C over another 2 h and to warm to room temperature while stirring for 18 h.  Subsequently, the 
reaction mixture was cooled to 0 °C and saturated aqueous ammonium chloride solution (120 
mL) was added.  The organic phase was separated, and the aqueous phase was extracted with 
three 50 mL aliquots of ether. The organic phases were combined and dried over sodium sulfate.  
After decanting, the solution was concentrated under reduced pressure yielding 7 (3.5 g, 35 
mmol, 82% yield) as a colorless oil, which was used in the next step without further purification.  
 
6.2. O-(t-butyldimethylsilyl)-2R-hex-5-enol 
 
A 250 mL round-bottom flask under argon was charged with a solution of 7 (3.51 g, 35 mmol) 
dissolved in dry DMF (60 mL).  The mixture was cooled to 0 °C prior to addition of imidazole 
(5.15 g, 76 mmol) and allowed to equilibrate for ten minutes.  tert-Butyldimethylsilyl chloride 
(10.4g, 69 mmol) was added via syringe, and the reaction mixture was allowed to stir 24 h while 
gradually warming to room temperature.  Subsequently, aqueous saturated NaHCO3 (200 mL) 
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was added to the mixture and the resulting biphasic solution was extracted with three 50 mL 
aliquots of pentane:ether (9:1 {v/v}).  Organic phases were combined and dried over sodium 
sulfate.  The solution was then decanted and concentrated under reduced pressure before being 
purified by silica gel column chromatography (1:10 ethyl acetate: hexanes to 1:2 ethyl acetate: 
hexanes {v/v}), yielding 8 (5.3 g, 25 mmol, 71%) as a colorless oil. 
 
6.3. 4R-(t-butyldimethylsilyloxy)pentanal 
 
To a solution of 8 (1.83 g, 7.5 mmol) in dry DCM (30 mL) sodium bicarbonate (20 mg) was 
added to neutralize any acid formation during ozonolysis.  The flask was cooled to -78 °C and 
ozone was bubbled through for four hours at an oxygen flow rate of about 10 ml/min.  It was 
observed that at this temperature, the reaction proceeded extremely slowly.  Therefore, the 
solution was allowed to warm very gradually to room temperature while ozone was continuously 
administered. After 16 h, dimethyl sulfide (15 g, 250 mmol) was added to the reaction vessel and 
the resulting solution stirred at room temperature for an additional 48 h.  Progress of the 
reduction of the ozonide was monitored by TLC. Subsequently, the solution was concentrated in 
vacuo and purified by silica gel column chromatography (12:1 hexanes:ethyl acetate {v/v}), 
yielding 0.93 g of 3 as a colorless, viscous liquid (4.3 mmol, 57%).  1H NMR (600 MHz, 
acetone-d6) δ  0.07 (s, 3 H, (CH3)2-Si), 0.073 (s, 3 H, (CH3)2-Si), 0.89 (s, 9 H, t-butyl), 1.14 (d, J 
= 6.1 Hz, 3 H, 5-H), 1.62-1.75 (m, 2 H, 3-H), 2.47-2.51 (m, 2 H, 2-H), 3.91 (m, 1 H, 6-H), 9.745 
(t, J = 1.6 Hz, 1 H, 1-H). 
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6.4. 6R-(t-butyldimethylsilyloxy)hept-2E-enoic acid ethyl ester 
 
To a solution of triethyl phosphonoacetate (0.62 g, 2.8 mmol) in trichloroacetonitrile (30 ml) 
stirred at room temperature, lithium chloride (0.18 g, 4.2 mmol), diisopropylethylamine (0.36 g, 
2.8 mmol), and 3 (0.30 g, 1.4 mmol) were added successively and the reaction was stirred 
overnight. Reaction progress was monitored via TLC (12:1 hexanes: ethyl acetate {v/v}) and was 
found to be complete after 42 h of stirring.  The solution was concentrated under reduced 
pressure and purified using silica gel column chromatography (1:8 ethyl acetate:hexanes to1:1 
ethyl acetate:hexanes {v/v}). The resulting viscous liquid was analyzed by 1H NMR and 
conclusively shows 9 with a 98:2 ratio favoring the desired trans arrangement across the double 
bond (0.36 g, 1.26 mmol, 90% yield). 1H NMR (500 MHz, acetone-d6) δ  0.07 (s, 6 H, (CH3)2-
Si), 0.89 (s, 9 H, t-butyl), 1.15 (d, J = 6.1 Hz, 3 H, 7-H), 1.23 (t, J = 7.2 Hz, 3 H, CH2CH3), 1.55-
1.60 (m, 2 H, 5-H), 2.21-2.39 (m, 2 H, 4-H), 3.90 (sext., J = 6.1 Hz, 1 H, 6-H), 4.12 (q, J = 7.1 
Hz, 2 H, CH2CH3), 5.83 (dt, J = 15.6, J = 1.6 Hz, 1 H, 2-H), 6.96 (dt, J = 15.6, J = 7.0 Hz, 1 H, 
3-H).   
 
6.5. 6R-hydroxyhept-2E-enoic acid ethyl ester 
 
To a vial containing 9 (0.36 g, 1.25 mmol) dissolved in acetonitrile (3 ml), 40% HF/H2O (0.75 
ml) was added drop-wise and the solution was allowed to stir for 1 h.  The reaction was judged 
complete by TLC (1:1 hexanes: ethyl acetate {v/v}), and aqueous saturated NaHCO3 solution (3 
ml) was added to neutralize the reaction.  Desired materials were extracted from the aqueous 
solution using three 1 ml-aliquots of 1:1 ether: pentanes.  Organic layers were combined and 
dried over sodium sulfate, filtered, and concentrated under reduced pressure before being 
purified by silica gel column chromatography (1:9 ethyl acetate:hexanes to 1:4 ethyl 
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acetate:hexanes {v/v}), yielding 4 as a colorless oil (0.16 g, 0.93 mmol, 74%). 1H NMR (600 
MHz, acetone-d6) δ  1.14 (d, J = 6.1 Hz, 3 H, 7-H), 1.23 (t, J = 7.2 Hz, 3 H, CH2CH3), 1.52-1.56 
(m, 2 H, 5-H), 2.25-2.31 (m, 1 H, 4-H), 2.34-2.39 (m, 1 H, 4-H), 3.71-3.77 (m, 1 H, 6-H), 4.12 
(q, J = 7.1 Hz, 2 H, CH2CH3), 5.83 (dt, J = 15.6, J = 1.6 Hz, 1 H, 2-H), 6.96 (dt, J = 15.6, J = 7.0 
Hz, 1 H, 3-H).   
 
6.6. 6R-(t-butyldimethylsiloxy)-2E-heptenoic acid  
 
To a solution of 9 (0.43 g, 1.5 mmol) dissolved in dioxane (20 ml), aqueous lithium hydroxide 
(0.25 g, 6 mmol in 4 ml H2O) was added and the resulting mixture was stirred at 60 °C 3 h. The 
resulting solution was concentrated in vacuo and re-suspended in ether (10 ml).  The reaction 
was neutralized by adding a suspension of potassium dihydrogenphosphate (2.5 g) in water (10 
ml), and the resulting biphasic mixture was extracted with two aliquots of ether (50 ml). Organic 
phases were combined and dried over sodium sulfate before being concentrated under reduced 
pressure, yielding 0.36 g (1.4 mmol, 93% yield) of 10 as a colorless oil.  
 
6.7. N-(6’R-[t-butyldimethylsiloxy]-2’E-heptenoyl)-4-aminobenzoic acid ethyl ester 
 
Oxalylchloride (0.08g, 0.62 mmol) was added to a solution of 10 (0.09g, 0.35 mmol) in DCM (2 
ml) at 0 °C.  One drop of DMF (0.04 ml) was added, and the solution was stirred for 20 min at 0 
°C.  The solution was then concentrated in vacuo and redissolved in dry DCM (2 ml).  After 
cooling to 0 °C, p-aminobenzoic acid (0.18 g, 1.1 mmol) followed by DIEA (0.18 g, 1.4 mmol) 
were added.  The solution was stirred at 0 °C  for 15 min, concentrated under reduced pressure, 
and purified by silica gel column chromatography (10:1 hexanes: ethyl acetate to 1:1 hexanes: 
13 
 
ethyl acetate {v/v}), yielding 12 (0.075 g, 0.19 mmol, 54%) as a colorless oil. 1H NMR (600 
MHz, CDCl3) δ 0.05 (s, 3 H, Si-CH3), 0.06  (s, 3 H, Si-CH3), 0.89 (s, 9 H, Si-C(CH3)3), 1.15 (d, J 
= 6.1 Hz, 3 H, 7-H), 1.38 (t, J = 7.1 Hz, 3 H, CH2CH3), 1.53-1.65 (m, 2 H, 5-H), 2.20-2.40 (m, 2 
H, 4-H), 3.80-3.88 (m, 1 H, 6-H), 4.36 (q, J = 7.1 Hz, 2 H, CH2CH3), 5.93 (dt, J = 15.2, J = 1.6 
Hz, 1 H, 2-H), 7.04 (dt, J = 15.2, J = 7.0 Hz, 1 H, 3-H), 7.25 (br. s, 1 H N-H), 7.63-7.66 (m, 2 H, 
p-aminobenzoyl), 8.00-8.03 (m, 2 H, p-aminobenzoyl). 
 
6.8. N-(6’R-hydroxy-2’E-heptenoyl)-4-aminobenzoic acid ethyl ester 
 
To a stirred solution of 12 (0.075 g, 0.19mmol) in acetonitrile (2 ml), one drop of 40% HF/H2O 
was added at room temperature.  Reaction progress was monitored using TLC (1:1 ethyl acetate: 
hexanes {v/v}) and was judged complete after 3 h.  The solution was then neutralized with 
saturated aqueous sodium bicarbonate and extracted with three 3-ml-aliquots of DCM.  Organic 
layers were combined and dried over sodium sulfate prior to concentration in vacuo.  The residue 
was purified by silica column chromatography (1:5 to 1:1 ethyl acetate: hexanes {v/v}), yielding 
5 (0.060 g, 0.19 mmol, 98%) as a colorless oil. 1H NMR (600 MHz, CDCl3) δ 1.22 (d, J = 6.1 
Hz, 3 H, 7-H), 1.38 (t, J = 7.1 Hz, 3 H, CH2CH3), 1.59-1.65 (m, 2 H, 5-H), 2.23-2.42 (m, 2 H, 4-
H), 3.84 (sext., J = 6.1 Hz, 1 H, 6-H), 4.35 (q, J = 7.1 Hz, 2 H, CH2CH3), 5.98 (dt, J = 15.2, J = 
1.6 Hz, 1 H, 2-H), 7.02 (dt, J = 15.2, J = 7.0 Hz, 1 H, 3-H), 7.60 (br. s, 1 H N-H), 7.65-7.67 (m, 
2 H, p-aminobenzoyl), 7.99-8.02 (m, 2 H, p-aminobenzoyl). 
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6.9. 5R-(3’R,5’R-dibenzoyloxy-6’S-methyl-(2H)-tetrahydropyran-2-yloxy)-2R-hexanol 
 
A solution of 6 (1.02 g, 2 mmol)6 and 2R,5R-hexanediol (13, 0.59 g, 5.0 mmol) in dry DCM (5 
ml) under argon was cooled to 0 °C.  Trimethylsilyl trifluoromethylsulfonate ([TMSOTF] 0.045 
g, 0.20 mmol) was added via syringe at 0 °C. Reaction progress was monitored by TLC (1:2 
ethyl acetate: hexanes {v/v}) and judged complete after 2 h.  The solution was allowed to warm 
to room temperature and was neutralized with saturated aqueous sodium bicarbonate solution (2 
ml).  The mixture was extracted with 1-ml-three portions of DCM and the organic phases were 
combined and dried over sodium sulfate prior to purification by silica gel column 
chromatography (1:5 ethyl acetate:hexanes to 1:1 ethyl acetate: hexanes {v/v}), yielding 14 (0.66 
g, 1.43 mmol, 72%) as a colorless oil. 1H NMR (600 MHz, benzene-d6) δ 1.00 (d, J = 6.1 Hz, 3 
H, 6-H), 1.015 (d, J = 6.1 Hz, 3 H, 1-H), 1.35 (d, J = 6.3 Hz, 3 H, 6’-CH3), 1.33-1.48 (m, 3 H), 
1.64-1.72 (m, 1 H), 2.25 (ddd, J = 13.8, J = 11.5, J = 3.1 Hz, 1 H, 4’-Hax), 2.35-2.56 (m, 1 H, 4’-
Heq), 3.55-4.60 (m, 1 H, 2-H), 3.75-3.80 (m, 1 H, 5-H), 4.35 (dq, J = 9.8, J = 6.3 Hz, 1 H, 6’-H), 
4.31 (q, J = 7.1 Hz, 2 H, CH2CH3), 5.17 (br. s, 1 H 2’-H), 5.35 (td, J = 3.1, J = 1.5 Hz, 1 H, 3’-
H), 5.64, (ddd, J = 11.3, J = 9.8, J = 4.8 Hz, 1 H 5’-H), 7.02-7.07 (m, 4 H, benzoyl), 7.10-7.15 
(m, 2 H, benzoyl), 8.11-8.13 (m, 2 H, benzoyl), 8.31-8.33 (m, 2 H, benzoyl). 
 
6.10. 5R-(3’R,5’R-dihydroxy-6’S-methyl-(2H)-tetrahydropyran-2-yloxy)-2R-hexanol 
(ascr#6.1) 
 
A solution of 14 (0.33 g, 0.72 mmol) was dissolved in methanol (4 ml) and 4 ml of a 0.5 M 
aqueous potassium hydroxide solution was added . Reaction progress was monitored by TLC 
(8:1 dichloromethane: methanol {v/v}).  Reaction was judged complete after 2 h, at which point 
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sodium bicarbonate (5 mg) was added to buffer the basic solution.  The reaction mixture was 
filtered over a cotton plug and the filtrate concentrated in vacuo followed by silica gel column 
chromatography (12:1 DCM:MeOH to 2:1 DCM: MeOH {v/v}), yielding ascr#6.1 (0.16 g, 0.66 
mmol, 93%) as a colorless oil, [α]D20 = -101, c 0.52 (methanol).  For NMR spectroscopic data 
see Supporting Table S1. 
 
6.11. 6R-(3’R,5’R-dibenzoyloxy-6’S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-heptenoic 
acid ethyl ester 
 
To a stirred solution of 6 (0.33 g, 0.66 mmol)6 and 4 (0.13 g, 0.75 mmol) in dry DCM (5 ml) at 0 
°C under argon TMSOTF (0.02 g, 0.083 mmol) was added via syringe.  Reaction progress was 
monitored by TLC (1:1 ethyl acetate: hexanes {v/v}) and judged complete after 4 h.  The reaction 
mixture was allowed to warm to room temperature gradually and was neutralized with saturated 
aqueous sodium bicarbonate solution (2 ml).  The mixture was extracted with three portions of 
DCM (1 ml), and the organic phases were combined and dried over sodium sulfate prior to 
purification by silica gel column chromatography (1:4 ethyl acetate:hexanes to 2:1 ethyl acetate: 
hexanes {v/v}), yielding 15 (0.33 g, 0.24 mmol, 36%) as a colorless oil. In addition, 60 mg (45%) 
of unreacted 4 was recovered. 
 
6.12. 6R-(3’R,5’R-dihydroxy-6’S-methyl-(2H)-tetrahydropyran-2-yloxy)-2E-heptenoic acid 
 
To a solution of 15 (0.33 g, 0.24 mmol) dissolved in dioxane (10 ml) and dry THF (6 ml), 
aqueous lithium hydroxide (10 ml 0.5 M solution) was added, and the resulting mixture was 
stirred at 70 °C for 3 h.  After cooling to room temperature, glacial acetic acid (0.60 g, 10 mmol) 
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was added with stirring.  The solution was concentrated under reduced pressure and purified by 
silica gel column chromatography (19:1 DCM:methanol to 6:1 DCM:methanol {v/v}), yielding 
ascr#7 (0.065 g, 0.24 mmol, 100%) as a colorless oil, [α]D20 = -85.3, c 3.2 (methanol). For NMR 
spectroscopic data see Supporting Table S3. 
 
6.13. N-(6’R-[3’’R,5’’R-dibenzoyloxy-6’’S-methyl-(2H)-tetrahydropyran-2-yloxy]-2’E-
heptenoyl)-4-aminobenzoic acid ethyl ester 
 
To a stirred solution of 6 (0.13g, 0.25 mmol) and 5 (0.067g, 0.23 mmol) in dry DCM (2 ml) at 0 
°C, TMSOTF (0.005 g, 0.025 mmol) was added.  Reaction progress was monitored by TLC (1:1 
ethyl acetate: hexanes {v/v}) and judged complete after 2 h.  The reaction mixture was allowed to 
warm to room temperature and was neutralized with saturated aqueous sodium bicarbonate 
solution (1 ml).  The mixture was extracted with 1-ml-three portions of DCM, and the organic 
phases were combined and dried over sodium sulfate prior to purification by silica gel column 
chromatography (1:10 ethyl acetate:hexanes to 1:1 ethyl acetate:hexanes {v/v}), yielding 16 (140 
mg, 0.22 mmol, 89 %) as a white powder. 1H NMR (500 MHz, acetone-d6) δ 1.25 (d, J = 6.1 Hz, 
3 H, 7-H), 1.27 (d, J = 6.3 Hz, 3 H, 6’-CH3), 1.35 (t, J = 7.2 Hz, 3 H, CH2CH3), 1.73-1.88 (m, 2 
H, 5-H), 2.26 (ddd, J = 14, J = 11.5, J = 3.0 Hz, 1 H, 4’-Hax), 2.35-2.56 (m, 3 H, 4-H, 4’-Heq), 
3.95-4.02 (m, 1 H, 6-H), 4.20 (dq, J = 9.8, J = 6.3 Hz, 1 H, 6’-H), 4.31 (q, J = 7.1 Hz, 2 H, 
CH2CH3), 5.03 (br. s, 1 H 2’-H), 5.12-5.18 (m, 2 H, 3’-H and 5’-H), 6.23 (dt, J = 15.1, J = 1.6 
Hz, 1 H, 2-H), 7.07 (dt, J = 15.1, J = 7.0 Hz, 1 H, 3-H), 7.49-7.55 (m, 2 H, benzoyl), 7.55-7.60 
(m, 2 H, benzoyl), 7.63-7.67 (m, 1 H, benzoyl), 7.67-7.72 (m, 1 H, benzoyl), 7.83-7.85 (m, 2 H, 
p-aminobenzoyl), 7.94-7.96  (m, 2 H, p-aminobenzoyl), 8.03-8.05 (m, 2 H, benzoyl), 8.10-8.12 
(m, 2 H, benzoyl). 
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6.14. N-(6’R-[3’’R,5’’R-dihydroxy-6’’S-methyl-(2H)-tetrahydropyran-2-yloxy]-2’E-
heptenoyl)-4-aminobenzoic acid (ascr#8) 
 
To a stirred solution of 16 (20 mg, 0.03 mmol) in dioxane (1 ml), 1 M aqueous lithium hydroxide 
solution (0.4 ml) and water (0.6 ml) were added and the resulting mixture was stirred at 62 °C 
for 3 h.  After cooling to room temperature, a solution of potassium dihydrogen phosphate (0.5 
g) in  water (10 ml) was added.  The entire mixture was concentrated in vacuo, re-suspended in 
methanol and evaporated onto Celite®. Silica gel column chromatography (20:1 DCM: methanol 
to 3:1 DCM: methanol {v/v}) yielded ascr#8 (12 mg, 0.03 mmol, ~100 %) as a white solid.  1H 
NMR spectroscopic analysis indicated the presence of 4-8% of the cis-isomer. Therefore, the 
material was further purified via reversed-phase HPLC, using aqueous ammonium acetate and 
methanol as solvents, as described in the following section 7.  Fractions containing ascr#8 were 
pooled and re-chromatographed (silica gel column chromatography using 20:1 DCM:methanol to 
3:1 DCM:methanol {v/v})) in order to remove ammonium acetate. Yield: 8 mg (0.02 mmol), 
[α]D20 = -48.0, c 0.35 (methanol). For NMR spectroscopic data see Table S4. 
 
7. Mass spectrometric analysis of metabolite extracts 
Metabolite extracts derived from 250 mL of daf-22 and N2 worm conditioned media were re-
suspended in 200 µL of 1:1 water:methanol mixture. The suspension was centrifuged, and 10 µl 
aliquots of the supernatant were submitted to HPLC-MS, using the Agilent HPLC system 
equipped with a Supelco Discovery HS C-18 column (25 cm x 10 mm, 5 µm particle diameter). 
A 40 mM ammonium acetate buffer-methanol solvent gradient was used, starting with a 
methanol content of 20%, which was increased to 100% over a period 30 min. For reference, 
synthetic samples of ascr#2, ascr#3, ascr#6.1, ascr#7 and ascr#8 were analyzed using the same 
method (Fig. S12-S16). These HPLC-MS analyses showed that wild-type liquid cultures 
contained variable amounts of ascarosides, generally in the range of 10-100 nM for ascr#1, 100-
200 nM for ascr#2, 100-200 nM for ascr#3, 10-20 nM for ascr#6.1 and ascr#6.2, 10-40 nM for 
ascr#7, and 10-70 nM for ascr#8.  
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Supporting Figure 1. Absolute-value representation of the 1-5 ppm section from the dqfCOSY
spectrum of wild-type (N2) metabolite extract.
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Supporting Figure 2a. DANS overlay of absolute-value dqfCOSY spectra from wild-type and daf-22 metabolite extracts, 
revealing compounds present in wildtype but absent in daf-22. Signals present in both wildtype and daf-22 spectra cancel or 
change color (blue), whereas signals representing compounds only present in wildtype remain unaffected (brown). Signals 
representing ascarosides are marked red. Several other groups of signals represent compounds not consistently expressed 
in either wildtype or daf 22 including an α D glucose derivative (marked with a blue asterisk “*”) a β alanine derivative
F2 (ppm)
    - ,   - -        ,  -  
(marked with a red asterisk “*”), alpha- and β-L-rhamnose (marked with a green asterisk “*”), as well as several other amino 
acid derivatives (marked with a green pound sign “#”).  Several other crosspeaks representing compounds present in both 
wild-type and daf-22 extracts appear incompletely suppressed because of small sample-specific differences in chemical shift 
values and as a result of the reduced resolution of the display.
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Supporting Figure 2b. Enhanced DANS overlay of absolute-value dqfCOSY spectra from wild-type and daf-22 metabolite 
extracts. A second daf-22 spectrum was superimposed on the spectrum shown in Supporting Figure 2a, resulting in better 
signal suppression. The second daf-22 spectrum was shifted by 5 Hz up-field in both dimensions, in order to compensate for 
concentration-dependent chemical shift changes. Especially amino acid derivatives are suppressed better.
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Supporting Figure 3. Signals detected via DANS were characterized further using the phase-
sensitive representation of the dqfCOSY spectrum of wild-type (N2) metabolite extract. 
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Supporting Figure 4. a: Section of absolute-value mode display of the dqfCOSY spectrum obtained form wild-type 
metabolite extract. b: Partial display of DANS overlay of absolute-value mode dqfCOSY spectra from wild-type and daf-22 
metabolite extracts. Signals present in both wildtype and daf-22 spectra cancel or change color (blue), whereas signals 
representing compounds only present in wildtype remain unaffected (brown). Signals representing ascarosides are 
marked c: Signals detected via DANS were characterized further using the phase sensitive representation of the.          -     
dqfCOSY spectrum in a. 
Supporting Figure 5. Phase-sensitive HSQC spectrum of wild-type (N2) metabolite extract.
Supporting Figure 6. 0.8-4.9 ppm section of the phase-sensitive HSQC spectrum of wild-type (N2) 
metabolite extract in Supporting Figure 5. Marked signals represent the side chains of ascr#2 (blue) and 
ascr#5 (red).
Supporting Figure 7. Magnitude-mode HMBC spectrum of wild-type (N2) metabolite extract. Marked signals 
represent the side chains of ascr#2 (blue) and ascr#5 (red).
Supporting Figure 8. 0.85-4.75 ppm section of the magnitude-mode HMBC spectrum of wild-type (N2) 
metabolite extract in Supporting Figure 7. Marked signals represent the side chains of ascr#2 (blue) and ascr#5 
(red).
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Supporting Figure 9. dqfCOSY spectrum of wild-type metabolite fraction containing ascr#6.1, ascr#6.2, and 
ascr#8 as major components. 
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Supporting Figure 10. NOESY spectrum of wild-type metabolite fraction containing ascr#6.1, ascr#6.2, 
and ascr#8 as major components. 
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Supporting Figure 11. HMBC spectrum of wild-type metabolite fraction containing ascr#6.1, ascr#6.2, and 
ascr#8 as major components. 
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Supporting Figure 12. HPLC-MS analysis of ascr#2. Combined ion chromatograms corresponding to [M+H]+ + [M+NH4]+ + 
[M+Na]+ are shown. (a) HPLC-MS chromatogram obtained for 45 pmol of ascr#2. (b) HPLC-MS chromatogram indicating presence 
of ascr#2 in wild-type metabolite extract. (c) HPLC-MS chromatogram indicating absence of ascr#2 in daf-22 metabolite extract. 
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Supporting Figure 13. HPLC-MS analysis of ascr#3. Combined ion chromatograms corresponding to [M+H]+ + [M+NH4]+ + 
[M+Na]+ are shown. (a) HPLC-MS chromatogram obtained for 45 pmol of ascr#3. (b) HPLC-MS chromatogram indicating presence 
of ascr#3 in wild-type metabolite extract. (c) HPLC-MS chromatogram indicating absence of ascr#3 in daf-22 metabolite extract. 
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Supporting Figure 14. HPLC-MS analysis of ascr#6.1. Combined ion chromatograms corresponding to [M+H]+ + [M+NH4]+ + 
[M+Na]+ are shown. (a) HPLC-MS chromatogram obtained for 0.45 nmol of ascr#6.1. (b) HPLC-MS chromatogram indicating 
presence of ascr#6.1 in wild-type metabolite extract. (c) HPLC-MS chromatogram indicating absence of ascr#6.1 in daf-22 metabolite 
extract. 
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Supporting Figure 15. HPLC-MS analysis of ascr#7. Combined ion chromatograms corresponding to [M+H]+ + [M+NH4]+ + 
[M+Na]+ are shown. (a) HPLC-MS chromatogram obtained for 45 pmol of ascr#7. (b) HPLC-MS chromatogram indicating presence 
of ascr#7 in wild-type metabolite extract. (c) HPLC-MS chromatogram indicating absence of ascr#7 in daf-22 metabolite extract. 
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Supporting Figure 16. HPLC-MS analysis of ascr#8. Combined ion chromatograms corresponding to [M+H]+ + [M+NH4]+ + 
[M+Na]+ are shown. (a) HPLC-MS chromatogram obtained for 45 pmol of ascr#8. (b) HPLC-MS chromatogram indicating presence 
of ascr#8 in wild-type metabolite extract. (c) HPLC-MS chromatogram indicating absence of ascr#8 in daf-22 metabolite extract. 
Supporting Figure 17. Hermaphrodites are not attracted to any of the ascarosides 
ascr#1-8, and males are not attracted to ascr#5. All compounds were assayed in 
amounts of 1 pmol. Data for ascr#1-4 has been published previously8.
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